Samsara Therapeutics
John is an experienced and successful drug discoverer at leading biotechs, most recently at Kymab where he delivered key haematology biologic assets into development. He started his industry career at IONTAS where he led the discovery of several immuno-oncology assets and he previously held positions at the University of Cambridge and the Mitochondrial Research group at the University of Newcastle. John obtained his Ph.D. at the University of Edinburgh.
This person is not in any offices
Samsara Therapeutics
Samsara Therapeutics, Inc. is a biopharmaceutical company aiming to discover the first-in-class therapeutics that treat rare genetic and neurodegenerative diseases and extend a healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy.